Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrenic nerve is a major peripheral nerve arising from the anterior rami of the C3–C5 cervical spinal nerves, primarily C4, and is the sole motor nerve to the diaphragm—the principal muscle of respiration[1][2][3][4]. It is a mixed nerve, conveying motor, sensory, and some sympathetic fibers. The phrenic nerve descends through the neck and thorax on each side to reach and innervate its respective hemidiaphragm. It provides motor stimulation to cause diaphragmatic contraction (essential for inhalation) and sensory fibers to key thoracic and upper abdominal structures, including the central diaphragm, pericardium, mediastinal pleura, and diaphragmatic peritoneum[1][2][3]. Damage to the phrenic nerve results in diaphragmatic paralysis or dysfunction, causing significant breathing difficulties, especially if both nerves are affected[1][2][3]. The phrenic nerve is anatomically a peripheral (somatic) nerve, not a molecular drug target such as a receptor, enzyme, channel, or transporter, and hence is not considered a canonical drug target for small molecules or biologics[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phrenic nerve.